ArticleMedical oncology (Northwood, London, England)2014

Systemic inflammation, as measured by the neutrophil/lymphocyte ratio, may have differential prognostic impact before and during treatment with fluorouracil, irinotecan and bevacizumab in metastatic colorectal cancer patients.

Vincenzo Formica et al.PubMed ↗Publisher ↗

No numbers read from the abstract.